Sarcopenia is the general term for a reduction in muscle quality and function due to aging. This is evidenced by muscle atrophy, particularly in fast type II fibres, which is related to the reduction of maximal voluntary strength (Deschenes, 2004). Sarcopenia has important socio-economic consequences since falls are a major source of morbidity and mortality in the increasing population of older adults (Mahoney et al., 1994). We tested the hypothesis that sarcopenia in humans may be linked to increased levels of TNFα and SOCS3; the latter causing perturbations in growth hormone (GH) signalling and increasing myostatin (Liu et al.2 003). Consequently,this would result in a reduced phosphorylation and activation of Akt signalling (Morissette et al., 2006) and therefore inhibit muscle hypertrophyand activate signalling cascades associated with muscle atrophy. The aims of the present study were to determine whether age-related sarcopenia in humans was linked with perturbations in TNFα,S OCS3, GH, STAT 5a nd IGF levels as well decreases in the Akt/GSK/mTOR and increases in the Akt/FKHR/atrogene signalling pathways.
